Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Substance use and older people
The identification Substance use among older people is often difficult and is frequently missed, particularly in the primary care context and in emergency departments.
The identification Substance use among older people is often difficult and is frequently missed, particularly in the primary care context and in emergency departments.
The rise and challenge of dark net drug markets
Recent years have seen a dramatic growth in the sale of a variety of illicit substances on Dark Net drug markets.
Recent years have seen a dramatic growth in the sale of a variety of illicit substances on Dark Net drug markets.
Different patterns of drug use and barriers to continuous HIV care post-incarceration
This article explores the processes by which a sample of adults experienced relapse post-incarceration and consequently experienced HIV treatment interruption.
This article explores the processes by which a sample of adults experienced relapse post-incarceration and consequently experienced HIV treatment interruption.
Cost-effectiveness of rapid hepatitis C virus testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
On-site rapid hepatitis C virus and HIV testing in substance abuse treatment programs is cost-effective at a <$100 000/quality-adjusted life year threshold.
On-site rapid hepatitis C virus and HIV testing in substance abuse treatment programs is cost-effective at a <$100 000/quality-adjusted life year threshold.
Measurement matters: Designing new metrics for a drug policy that works
This paper produced by the Igarape Institute proposes a new set of generic goals, targets and indicators to track the intended and unintended consequences of drug policy and to improve public health, safety and citizen security.
This paper produced by the Igarape Institute proposes a new set of generic goals, targets and indicators to track the intended and unintended consequences of drug policy and to improve public health, safety and citizen security.
Psychophysiology of pain and opioid use: Implications for managing pain in patients with an opioid use disorder
More research is needed into the psychophysiological biomarkers among individuals with comorbid pain and addiction in order to develop better treatment approaches.
More research is needed into the psychophysiological biomarkers among individuals with comorbid pain and addiction in order to develop better treatment approaches.
Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: Results from National HIV Behavioral Surveillance 2005–2012
Despite the improvement in some health measures for PWIDs in San Francisco from 2005 to 2012, there is a need for renewed attention and innovative ideas to track and address HIV and other medical sequelae among PWIDs.
Despite the improvement in some health measures for PWIDs in San Francisco from 2005 to 2012, there is a need for renewed attention and innovative ideas to track and address HIV and other medical sequelae among PWIDs.
Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: Results of a randomized crossover study
This study supports positive effects of slow-release oral morphine compared to methadone on patient-reported outcomes such as mental symptoms and treatment satisfaction with comparable effects on concomitant drug use.
This study supports positive effects of slow-release oral morphine compared to methadone on patient-reported outcomes such as mental symptoms and treatment satisfaction with comparable effects on concomitant drug use.
Overdose prevention: Findings
The 2013 may prove to have been a turning point in the drug-related deaths in the UK, as national naloxone programmes seem to be denting the high death rates. However, despite recent good news, the drug-related death rate in Scotland remains dramatically excesive.
The 2013 may prove to have been a turning point in the drug-related deaths in the UK, as national naloxone programmes seem to be denting the high death rates. However, despite recent good news, the drug-related death rate in Scotland remains dramatically excesive.
Dealing with drug problem from public health and human rights perspectives in Liberia
The Liberian public health law emphasises on criminalisation of illicit drug usage punishable by imprisonment without rehabilitation and anybody caught by state security actors in relation to perceived ‘drug crime’ is sent to prison without legal proceedings.
The Liberian public health law emphasises on criminalisation of illicit drug usage punishable by imprisonment without rehabilitation and anybody caught by state security actors in relation to perceived ‘drug crime’ is sent to prison without legal proceedings.
